… by supporting the private domestic pharmaceutical industry, and announced in … tending to over-prescribe so pharmacies profit. Mexico has one of … for copying <h1>Big Pharma Is Making Mexico … tending to over-prescribe so pharmacies profit.</p> …

… therapies. Consequently, operating profits for the company climbed … in fourth-quarter revenue alone. These revenue streams confirm that … the central pillar of pharmaceutical value creation. Historic Capital … Group sales for the first half of 2024/25 …

The federal No Surprises Act went into effect in 2022 with the goal of preventing surprise billing by implementing an independent dispute resolution process for payment disputes between payers and out-of-network providers.   In a Dec. 18 episode of Keeping …

… 2027. The not-for-profit also announced it would start … investment in the not-for-profit’s history, costing an … including electroconvulsive therapy, imagery, a pharmacy, chapel, café, gym, hydrotherapy … expected to start in the first half of 2026, with hopes …

Nyxoah Announces Issuance of First Tranche of Convertible Bonds Mont-Saint-Guibert, Belgium – December 19, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused …

… Fagron NV, a global pharmaceutical compounding leader headquartered in Waregem … ” million euros in annual revenues, with the EBITDA margin … strategic fit and expected profitability. In a more recent … were recorded in the first half of 2025, with manufacturing …

… on-year in the first half. Analysts at KPMG Korea … 80 percent of total revenue in the third quarter, … industries, from cosmetics to pharmaceuticals. Amorepacific, for instance, … high-performance beauty devices. PharmaResearch, a local biopharmaceutical company …

FTSE 100 up 5 points at 9,779 BP replaces CEO after less than 2yrs Currys tops FTSE 350 risers after results  9.06am: Currys good H1 but only 10% of full year  Currys shares are up over 6% on some strong first-half results.  Analyst John Stevenson at Peel …

… surveillance and allowing pharmaceutical companies to reap massive profits from our pain … that was just during the first half of the ’70s. Hersh’s …

TAICHUNG CITY, Taiwan, Dec. 18, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications including personal …